Advanced search
Publication Cover
Diabetes, Metabolic Syndrome and Obesity Volume 15, 2022 - Issue
Submit an article Journal homepage
138
Views
0
CrossRef citations to date
0
Altmetric
RESPONSE TO LETTER

Awareness of Genetic Polymorphism in Drug Metabolizing Enzymes and Transporters May Promote Personalized Type 2 Diabetes Management [Response to Letter]

David M Williams1 Department of Diabetes and Endocrinology, Morriston Hospital, Swansea Bay University Health Board, Swansea, SA6 8NL, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9206-5837
ORCID Icon &
Jeffrey W Stephens1 Department of Diabetes and Endocrinology, Morriston Hospital, Swansea Bay University Health Board, Swansea, SA6 8NL, UK;2 Diabetes Research Group, Swansea University Medical School, Swansea University, Swansea, SA2 8PP, UKORCID Iconhttps://orcid.org/0000-0003-2228-086X
ORCID Icon
Pages 741-742 | Published online: 07 Mar 2022
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
"Awareness of Genetic Polymorphism in Drug Metabolizing Enzymes and Transporters May Promote Personalized Type 2 Diabetes Management [Response to Letter]." Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, , pp. 741–742
This article responds to:
Awareness of Genetic Polymorphism in Drug Metabolizing Enzymes and Transporters May Promote Personalized Type 2 Diabetes Management [Letter]

Disclosure

The authors report no conflicts of interest in this communication.

Download PDF

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.